Hypoxia and tumor-associated macrophages: A deadly alliance in support of tumor progression

OncoImmunology

Volumn 3, Issue 1, 2014, Pages

  Overmeire, Eva Van ^a,b   Laoui, Damya ^a,b   Keirsse, Jiri ^a,b   Van Ginderachter, Jo A ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

CD206; Hypoxia; M1; M2; Molecular imaging; Nanobody; PHD2; Tumor associated macrophage

Indexed keywords

ARGINASE 1; CD204 ANTIGEN; CD206 ANTIGEN; CD68 ANTIGEN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HYPOXIA INDUCIBLE FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; BLOOD OXYGEN TENSION; CANCER PROGNOSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; HYPOXIA; IMMUNOSTIMULATION; METASTASIS; MICRO-COMPUTED TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR MODEL;

EID: 84899080460     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.27561     Document Type: Article

References (10)

1. Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW, Wei YQ. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One 2012; 7:e50946; PMID:23284651; http://dx.doi. org/10.1371/journal.pone.0050946.
2. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j. cell.2010.03.014.
3. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501:346-54; PMID:24048067; http://dx.doi.org/10.1038/nature12626.
4. Movahedi K, Laoui D, Gysemans C, Baeten M, Stangé G, Van den Bossche J, Mack M, Pipeleers D, In't Veld P, De Baetselier P, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010; 70:5728-39; PMID:20570887; http://dx.doi.org/10.1158/0008-5472.CAN-09-4672.
5. Matsumoto S, Yasui H, Mitchell JB, Krishna MC. Imaging cycling tumor hypoxia. Cancer Res 2010; 70:10019-23; PMID:21159626; http://dx.doi. org/10.1158/0008-5472.CAN-10-2821.
6. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104:2224-34; PMID:15231578; http://dx.doi.org/10.1182/blood-2004-03-1109.
7. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009; 136:839-51; PMID:19217150; http://dx.doi.org/10.1016/j.cell.2009.01.020.
8. Laoui D, Van Overmeire E, Di Conza G, Aldeni C, Keirsse J, Morias Y, Movahedi K, Houbracken I, Schouppe E, Elkrim Y, et al. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. [e-pub ahead of print]. Cancer Res 2013; PMID:24220244; http://dx.doi.org/10.1158/0008-5472.CAN-13-1196.
9. Chitneni SK, Palmer GM, Zalutsky MR, Dewhirst MW. Molecular imaging of hypoxia. J Nucl Med 2011; 52:165-8; PMID:21233176; http://dx.doi. org/10.2967/jnumed.110.075663.
10. Movahedi K, Schoonooghe S, Laoui D, Houbracken I, Waelput W, Breckpot K, Bouwens L, Lahoutte T, De Baetselier P, Raes G, et al. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Res 2012; 72:4165-77; PMID:22719068; http://dx.doi.org/10.1158/0008-5472.CAN-11-2994.